Design and synthesis of a novel synthetic NAPAP-penta-saccharide conjugate displaying a dual antithrombotic action.

The synthesis of a novel antithrombotic consisting of a heparin pentasaccharide conjugated to the active site inhibitor N-(2-naphtalenesulfonyl)-glycyl-(D)-4-aminophenyl-alanyl-piperidin e (NAPAP) (i.e. compound I) is reported. This conjugate shows a unique pharmacological profile both in vitro and in vivo having direct anti-thrombin and ATIII-mediated anti-Xa activity. Furthermore, conjugate I has a prolonged in vivo half-life compared to NAPAP (1.5 h vs 9 min.).

[1]  M. Petitou,et al.  The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics , 1993 .

[2]  S. Balasubramanian,et al.  A convenient synthetic route to oligonucleotide conjugates , 1997 .

[3]  J. H. Boom,et al.  Synthesis of a Pentasaccharide–Oligonucleotide Conjugate: A Novel Antithrombotic Agent , 1996 .

[4]  P. Grootenhuis,et al.  Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity , 1995, Nature Structural Biology.

[5]  C. V. van Boeckel,et al.  Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide. , 1994, Bioorganic & medicinal chemistry.

[6]  M. Petitou,et al.  Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. , 1983, Biochemical and biophysical research communications.

[7]  P. Zandberg,et al.  Two New Closely Related Rat Models with Relevance to Arterial Thrombosis – Efficacies of Different Antithrombotic Drugs , 1997, Thrombosis and Haemostasis.

[8]  J. Stürzebecher,et al.  Cyclic amides of N alpha-arylsulfonylaminoacylated 4-amidinophenylalanine--tight binding inhibitors of thrombin. , 1983, Thrombosis research.

[9]  D. Lane,et al.  Heparin: Chemical and Biological Properties Clinical Applications , 1989 .

[10]  U Lindahl,et al.  Further characterization of the antithrombin-binding sequence in heparin. , 1982, Carbohydrate research.